Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T22:50:35.871Z.
Calculation as of: 2026-10-06T22:50:35.871Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: a5ea7848df566bb1fba137e14a23bd7a424b67da13a14cf2752e181034030ce3
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Market Cap
$32.79M
Operating Cash Flow Yield
N/A
TTM Avg
4.07%
3Y Avg
3.32%
5Y Avg
3.32%
Market Cap
$32.93M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$33.29M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$31.52M
Operating Cash Flow Yield
9.73%
TTM Avg
9.00%
3Y Avg
11.41%
5Y Avg
14.06%
Market Cap
$33.61M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$33.63M
Operating Cash Flow Yield
N/A
TTM Avg
26.21%
3Y Avg
25.33%
5Y Avg
25.33%
Market Cap
$31.11M
Operating Cash Flow Yield
N/A
TTM Avg
13.07%
3Y Avg
8.54%
5Y Avg
8.65%
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| HeartBeam, Inc. (BEAT) | $32.42M | N/A | N/A | N/A | N/A |
| Nephros, Inc. (NEPH)vs › | $32.79M | N/A | 4.07% | 3.32% | 3.32% |
| Baird Medical Investment Holdings Limited (BDMD)vs › | $32.93M | N/A | N/A | N/A | N/A |
| Aligos Therapeutics, Inc. (ALGS)vs › | $33.29M | N/A | N/A | N/A | N/A |
| Nortech Systems Incorporated (NSYS)vs › | $31.52M | 9.73% | 9.00% | 11.41% | 14.06% |
| Grace Therapeutics, Inc. (GRCE)vs › | $33.61M | N/A | N/A | N/A | N/A |
| Scilex Holding Company (SCLX)vs › | $33.63M | N/A | 26.21% | 25.33% | 25.33% |
| Accuray Incorporated (ARAY)vs › | $31.11M | N/A | 13.07% | 8.54% | 8.65% |
| CervoMed Inc. (CRVO)vs › | $30.92M | N/A | N/A | N/A | N/A |
| MDxHealth S.A. (MDXH)vs › | $30.81M | N/A | N/A | N/A | N/A |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
